Aggregates form in the eyes of flies expressing Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4GMR.PF. Fewer aggregates are observed after treatment with compounds SEN177 and SEN180.
The expression of Hsap\HTTQ46.ex1p.UAS.EGFP under the control of Scer\GAL4P2.4.Pdf does not seem to have a major effect on circadian behavior, nor on the number of sLNv neurons.
Aggregates form in the eyes of aged flies expressing Scer\GAL4GMR.PF>Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP.
Expression of Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4HCH.Hand results in a small but significant decrease in lifespan compared to controls.
3 week old flies expressing Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4HCH.Hand show a significant increase in systolic diameter, diastolic diameter, systolic interval, diastolic interval and cardiac arrhythmia compared to controls. Fractional shortening is significantly decreased. In addition morphological defects such as non-beating hearts, hearts with non-contractile regions and defective ostia are seen.
Myocardial cells of 4 week old flies expressing Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4HCH.Hand show myofibrillar degeneration and severe mitochondrial fragmentation.
Flies expressing Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4GMR.PU show age-dependent formation of Hsap\HTT protein aggregates in the eye.
Flies expressing Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP under the control of Scer\GAL4elav.PU show age-dependent formation of Hsap\HTT protein aggregates in the brain.
Hsap\HTTQ46.ex1p.UAS.EGFP, Scer\GAL4GMR.PF has eye phenotype, suppressible by CalpAKK104532, Scer\GAL4GMR.PF
Hsap\HTTQ46.ex1p.UAS.EGFP, Scer\GAL4GMR.PF has eye phenotype, suppressible by Dcr-2UAS.cDa/CalpANIG.7563R, Scer\GAL4GMR.PF
Hsap\HTTQ46.ex1p.UAS.EGFP, Scer\GAL4GMR.PF has eye phenotype, suppressible by Dcr-2UAS.cDa/CalpANIG.18152R, Scer\GAL4GMR.PF
Hsap\HTTQ46.ex1p.UAS.EGFP, Scer\GAL4GMR.PF has eye phenotype, non-suppressible by Dcr-2UAS.cDa/CalpAKK104532/Atg8aKG07569, Scer\GAL4GMR.PF
Co-expression of CalpAKK104532 results in a clear reduction in the number of aggregates observed in the eyes of flies expressing Scer\GAL4GMR.PF>Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP.
Co-expression of CalpANIG.7563R results in a clear reduction in the number of aggregates observed in the eyes of flies expressing Scer\GAL4GMR.PF>Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP.
Co-expression of CalpANIG.18152R results in a clear reduction in the number of aggregates observed in the eyes of flies expressing Scer\GAL4GMR.PF>Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP.
Co-expression of CalpAKK104532 in an Atg8aKG07569 mutant genetic background fails to reduce the number of aggregates observed in the eyes of flies expressing Scer\GAL4GMR.PF>Hsap\HTTQ46.ex1p.Scer\UAS.T:Avic\GFP-EGFP.